NO20092359L - Aminoalkoholderivater og deres terapeutiske anvendelse - Google Patents

Aminoalkoholderivater og deres terapeutiske anvendelse

Info

Publication number: NO20092359L
Authority: NO; Norway
Prior art keywords: alkyl; ring; ch2oh; optionally substituted; ch2or6
Prior art date: 2006-12-12

Application number

NO20092359A

Other languages

English (en)

Norwegian (no)

Inventor

Andrea Walmsley

Elena Lasterra

Original Assignee

Sosei R & D Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-12-12

Filing date

2009-06-19

Publication date

2009-07-08

2009-06-19 Application filed by Sosei R & D Ltd filed Critical Sosei R & D Ltd

2009-07-08 Publication of NO20092359L publication Critical patent/NO20092359L/no

Links

230000001225 therapeutic effect Effects 0.000 title abstract 2
150000001414 amino alcohols Chemical class 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 10
CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 abstract 5
101100134929 Gallus gallus COR9 gene Proteins 0.000 abstract 2
125000003118 aryl group Chemical group 0.000 abstract 2
125000001072 heteroaryl group Chemical group 0.000 abstract 2
102000004127 Cytokines Human genes 0.000 abstract 1
108090000695 Cytokines Proteins 0.000 abstract 1
-1 OCOR9 Chemical group 0.000 abstract 1
230000006052 T cell proliferation Effects 0.000 abstract 1
230000003110 anti-inflammatory effect Effects 0.000 abstract 1
125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000000753 cycloalkyl group Chemical group 0.000 abstract 1
125000005842 heteroatom Chemical group 0.000 abstract 1
230000001404 mediated effect Effects 0.000 abstract 1
230000000770 proinflammatory effect Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C219/20—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
- C07C219/22—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Ophthalmology & Optometry (AREA)
Orthopedic Medicine & Surgery (AREA)
Dermatology (AREA)
Urology & Nephrology (AREA)
Transplantation (AREA)
Emergency Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pyrane Compounds (AREA)

NO20092359A 2006-12-12 2009-06-19 Aminoalkoholderivater og deres terapeutiske anvendelse NO20092359L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0624757.1A GB0624757D0 (en)	2006-12-12	2006-12-12	Novel compounds
PCT/GB2007/004752 WO2008071948A2 (en)	2006-12-12	2007-12-12	Aminoalcohol derivatives and their therapeutic use

Publications (1)

Publication Number	Publication Date
NO20092359L true NO20092359L (no)	2009-07-08

Family

ID=37711970

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20092359A NO20092359L (no)	2006-12-12	2009-06-19	Aminoalkoholderivater og deres terapeutiske anvendelse

Country Status (14)

Country	Link
US (1)	US20100076068A1 (pt)
EP (2)	EP2518049A3 (pt)
JP (1)	JP5225287B2 (pt)
KR (1)	KR20090088442A (pt)
CN (1)	CN101573325A (pt)
AU (1)	AU2007331337A1 (pt)
BR (1)	BRPI0720284A2 (pt)
CA (1)	CA2672238A1 (pt)
GB (1)	GB0624757D0 (pt)
IL (1)	IL199178A0 (pt)
MX (1)	MX2009006246A (pt)
NO (1)	NO20092359L (pt)
WO (1)	WO2008071948A2 (pt)
ZA (1)	ZA200903942B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2018111003A1 (ko) *	2016-12-14	2018-06-21	에스케이바이오팜 주식회사	가려움증의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도
GB201714734D0 (en)	2017-09-13	2017-10-25	Atrogi Ab	New compounds and uses
GB201714740D0 (en)	2017-09-13	2017-10-25	Atrogi Ab	New compounds and uses
GB201714736D0 (en)	2017-09-13	2017-10-25	Atrogi Ab	New compounds and uses
GB201714745D0 (en)	2017-09-13	2017-10-25	Atrogi Ab	New compounds and uses
GB201903832D0 (en)	2019-03-20	2019-05-01	Atrogi Ab	New compounds and methods

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH246387A (de) *	1945-06-12	1946-12-31	H Dr Herzog	Verfahren zur Herstellung eines Ephedrinderivates.
US2900415A (en) *	1954-12-14	1959-08-18	Lakeside Lab Inc	Synthesized antispasmodic compounds
US4166452A (en)	1976-05-03	1979-09-04	Generales Constantine D J Jr	Apparatus for testing human responses to stimuli
JPS609713B2 (ja) *	1976-10-08	1985-03-12	大塚製薬株式会社	カルボスチリル誘導体
US4256108A (en)	1977-04-07	1981-03-17	Alza Corporation	Microporous-semipermeable laminated osmotic system
DE2817494A1 (de) *	1977-05-03	1978-11-09	Continental Pharma	Aminoalkohol-derivat
US4638070A (en) *	1978-12-21	1987-01-20	Continental Pharma	Heterocyclic amino-alcohol derivatives
US4265874A (en)	1980-04-25	1981-05-05	Alza Corporation	Method of delivering drug with aid of effervescent activity generated in environment of use
FR2555576B1 (fr) *	1983-11-25	1986-06-13	Lafon Labor	Derives de n-(methoxyphenacyl)-amine, utilisation notamment en therapeutique et procede de preparation
IT1222986B (it) *	1987-10-23	1990-09-12	Texcontor Ets	Derivati dell'efedrina esterificata aventi attivita' antiulcera prolungata nel tempo
DE69118700D1 (de) *	1990-08-13	1996-05-15	Searle & Co	Verwendung von heterozyklischen aminoalkoholverbindungen zur herstellung eines medikaments für die behandlung von erkrankungen des zns
US5264459A (en) *	1992-07-13	1993-11-23	Arch Development Corporation	Use of β-adrenergic agonists to treat patients with demyelinating or autoimmune diseases
US6337328B1 (en) *	1999-03-01	2002-01-08	Sepracor, Inc.	Bupropion metabolites and methods of use
US6646135B1 (en) *	1999-06-23	2003-11-11	Roche Vitamins Inc.	Continuous process for the enantioselective hydrogenation of alpha ketocarbonyl compounds
US6560347B2 (en) *	2000-12-19	2003-05-06	Samsung Electro-Mechanics Co., Ltd.	Multi actuator
US20040002546A1 (en) *	2001-09-15	2004-01-01	Eric Altschuler	Methods for treating crohn's and other TNF associated diseases
WO2006027579A2 (en) *	2004-09-07	2006-03-16	Sosei R & D Ltd.	The treatment of inflammatory disorders and pain
IL166149A0 (en) *	2005-01-05	2006-01-15	Hadasit Med Res Service	Use of ezetimibe and amiodarone in protection against beta-amyloid neurotoxicity
WO2006102476A2 (en) *	2005-03-21	2006-09-28	Vicus Therapeutics Spe 1, Llc	Compositions and methods for ameliorating cachexia
ATE481096T1 (de) *	2005-04-06	2010-10-15	Adamas Pharmaceuticals Inc	Verfahren und zusammensetzungen zur behandlung von zns-erkrankungen
CN101203214B (zh) *	2005-04-13	2012-11-21	艾升制药公司	用于治疗皮肤结缔组织疾病的β2-肾上腺素受体激动剂
GB0519274D0 (en) *	2005-09-21	2005-11-02	Arakis Ltd	The treatment of neurodegenerative diseases
GB0526123D0 (en) *	2005-12-22	2006-02-01	Univ Gent	Synephrine derivatives useful as anti-inflammatory agents
GB0604822D0 (en) *	2006-03-09	2006-04-19	Arakis Ltd	The treatment of inflammatory disorders and pain
GB0604824D0 (en) *	2006-03-09	2006-04-19	Arakis Ltd	The treatment of inflammatory disorders

2006
- 2006-12-12 GB GBGB0624757.1A patent/GB0624757D0/en not_active Ceased
2007
- 2007-12-12 US US12/517,272 patent/US20100076068A1/en not_active Abandoned
- 2007-12-12 EP EP12174501.2A patent/EP2518049A3/en not_active Withdrawn
- 2007-12-12 ZA ZA200903942A patent/ZA200903942B/xx unknown
- 2007-12-12 CA CA002672238A patent/CA2672238A1/en not_active Abandoned
- 2007-12-12 AU AU2007331337A patent/AU2007331337A1/en not_active Abandoned
- 2007-12-12 WO PCT/GB2007/004752 patent/WO2008071948A2/en not_active Ceased
- 2007-12-12 JP JP2009540849A patent/JP5225287B2/ja not_active Expired - Fee Related
- 2007-12-12 MX MX2009006246A patent/MX2009006246A/es not_active Application Discontinuation
- 2007-12-12 CN CNA2007800458639A patent/CN101573325A/zh active Pending
- 2007-12-12 BR BRPI0720284-9A patent/BRPI0720284A2/pt not_active IP Right Cessation
- 2007-12-12 EP EP07848496A patent/EP2118050A2/en not_active Withdrawn
- 2007-12-12 KR KR1020097014285A patent/KR20090088442A/ko not_active Withdrawn
2009
- 2009-06-04 IL IL199178A patent/IL199178A0/en unknown
- 2009-06-19 NO NO20092359A patent/NO20092359L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
US20100076068A1 (en)	2010-03-25
GB0624757D0 (en)	2007-01-17
ZA200903942B (en)	2010-08-25
EP2518049A2 (en)	2012-10-31
AU2007331337A1 (en)	2008-06-19
WO2008071948A3 (en)	2008-07-31
IL199178A0 (en)	2010-03-28
CA2672238A1 (en)	2008-06-19
EP2518049A3 (en)	2013-07-10
JP5225287B2 (ja)	2013-07-03
EP2118050A2 (en)	2009-11-18
BRPI0720284A2 (pt)	2014-01-28
CN101573325A (zh)	2009-11-04
WO2008071948A2 (en)	2008-06-19
KR20090088442A (ko)	2009-08-19
MX2009006246A (es)	2009-07-16
JP2010512378A (ja)	2010-04-22

Legal Events

Date	Code	Title	Description
2013-07-29	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20092359L (no)	2009-07-08	Aminoalkoholderivater og deres terapeutiske anvendelse
RU2497807C2 (ru)	2013-11-10	Карбазольные соединения и терапевтические применения соединений
CL2012001171A1 (es)	2012-08-10	Procedimiento para la preparacion del ester n-[[2-[[[4-[[[(hexiloxicarbonil)]4-amino]iminometil]fenil]amino]metil]1-alquil-1h-benzimidazol-5-il]carbonil]n-2-piridinil-etilico de beta-alanina; y uno de los compuestos intermediarios considerados.
RU2007116038A (ru)	2009-04-10	Циклические диарилмочевины, используемые в качестве ингибиторов тирозинкиназы
ATE537169T1 (de)	2011-12-15	Piperidin- und piperazinderivate als p2x3- antagonisten
RU2006146070A (ru)	2008-07-10	Циннамидное соединение
NZ595432A (en)	2013-12-20	4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2
PE20090770A1 (es)	2009-06-24	Derivados de benzoxazolona
MX2009008465A (es)	2009-08-20	Nuevas 2-aminooxazolinas como ligandos de taar1.
NZ586082A (en)	2013-03-28	Indole compounds and methods for treating visceral pain
MX2010006202A (es)	2011-03-04	Derivados de oxindol substituidos por amidometil y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina.
NO20080738L (no)	2008-04-10	Fremgangsmater for neurobeskyttelse
AR059328A1 (es)	2008-03-26	Derivados de antranilamida-2-amino-heteroareno-carboxamida, un proceso para su obtencion, composiciones farmaceuticas que los contienen y el uso de estos compuestos para la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por cetp
NO330968B1 (no)	2011-08-29	Ny fremgangsmate for syntesen av (1S)-4,5-dimetoksy-1-(metylaminometyl)-benzocyklobutan og addisjonssalter derav, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre
PE20090592A1 (es)	2009-05-03	Nuevos derivados de piperazina-amida
SE0302324D0 (sv)	2003-08-28	Novel compounds
RU2011127451A (ru)	2013-01-10	ПРОИЗВОДНЫЕ ТИЕНО[3,2-c]ПИРИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ КИНАЗ ДЛЯ ПРИМЕНЕНИЯ В ЛЕЧЕНИИ РАКА
JP2007519695A5 (pt)	2008-03-13
DE602005016775D1 (de)	2009-11-05	Heterocyclische, ein azol enthaltende sulfonamidinhibitoren der beta-amyloid-produktion
NO20061126L (no)	2006-05-09	Aminopyroner og deres anvendelse som ATM-inhibitorer
SE0302323D0 (sv)	2003-08-28	Novel compounds
PE20091243A1 (es)	2009-09-07	Compuesto heterociclico fusionado
CO6140035A2 (es)	2010-03-19	Derivados de bencimidazol 5-sulfonamida como ligandos del receptor cannabinoide 1 (cb1)
RU2010130418A (ru)	2012-01-27	Производные 4-аминопиримидина
ATE478054T1 (de)	2010-09-15	Benzimidazolderivate